Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1954 3
1955 4
1956 1
1957 3
1959 1
1960 1
1961 1
1962 3
1963 3
1964 12
1965 3
1966 9
1967 9
1968 7
1969 5
1970 3
1971 1
1972 3
1973 2
1974 1
1975 3
1976 1
1977 7
1978 2
1979 2
1980 1
1981 1
1982 2
1983 1
1984 2
1985 4
1986 7
1987 4
1988 4
1989 6
1990 6
1991 6
1992 4
1993 6
1994 10
1995 11
1996 10
1997 6
1998 3
1999 6
2000 4
2001 5
2002 8
2003 6
2004 15
2005 16
2006 17
2007 17
2008 24
2009 16
2010 10
2011 16
2012 21
2013 23
2014 21
2015 19
2016 29
2017 33
2018 27
2019 36
2020 41
2021 48
2022 6
Text availability
Article attribute
Article type
Publication date

Search Results

606 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy and Safety of Guselkumab, an Interleukin-23p19-Specific Monoclonal Antibody, Through One Year in Biologic-Naive Patients With Psoriatic Arthritis.
McInnes IB, Rahman P, Gottlieb AB, Hsia EC, Kollmeier AP, Chakravarty SD, Xu XL, Subramanian RA, Agarwal P, Sheng S, Jiang Y, Zhou B, Zhuang Y, van der Heijde D, Mease PJ. McInnes IB, et al. Among authors: chakravarty sd. Arthritis Rheumatol. 2021 Apr;73(4):604-616. doi: 10.1002/art.41553. Epub 2021 Mar 17. Arthritis Rheumatol. 2021. PMID: 33043600 Clinical Trial.
Comparative effectiveness of guselkumab in psoriatic arthritis: results from systematic literature review and network meta-analysis.
Mease PJ, McInnes IB, Tam LS, Eaton K, Peterson S, Schubert A, Chakravarty SD, Parackal A, Karyekar CS, Nair S, Boehncke WH, Ritchlin C. Mease PJ, et al. Among authors: chakravarty sd. Rheumatology (Oxford). 2021 May 14;60(5):2109-2121. doi: 10.1093/rheumatology/keab119. Rheumatology (Oxford). 2021. PMID: 33844022 Free PMC article.
Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions.
Krishnan V, Han MH, Graham DL, Berton O, Renthal W, Russo SJ, Laplant Q, Graham A, Lutter M, Lagace DC, Ghose S, Reister R, Tannous P, Green TA, Neve RL, Chakravarty S, Kumar A, Eisch AJ, Self DW, Lee FS, Tamminga CA, Cooper DC, Gershenfeld HK, Nestler EJ. Krishnan V, et al. Among authors: chakravarty s. Cell. 2007 Oct 19;131(2):391-404. doi: 10.1016/j.cell.2007.09.018. Cell. 2007. PMID: 17956738 Free article.
Guselkumab, an inhibitor of the IL-23p19 subunit, provides sustained improvement in signs and symptoms of active psoriatic arthritis: 1 year results of a phase III randomised study of patients who were biologic-naïve or TNFα inhibitor-experienced.
Ritchlin CT, Helliwell PS, Boehncke WH, Soriano ER, Hsia EC, Kollmeier AP, Chakravarty SD, Zazzetti F, Subramanian RA, Xu XL, Zuraw QC, Sheng S, Jiang Y, Agarwal P, Zhou B, Zhuang Y, Shawi M, Karyekar CS, Deodhar A. Ritchlin CT, et al. Among authors: chakravarty sd. RMD Open. 2021 Feb;7(1):e001457. doi: 10.1136/rmdopen-2020-001457. RMD Open. 2021. PMID: 33568556 Free PMC article. Clinical Trial.
Atypical B cells are part of an alternative lineage of B cells that participates in responses to vaccination and infection in humans.
Sutton HJ, Aye R, Idris AH, Vistein R, Nduati E, Kai O, Mwacharo J, Li X, Gao X, Andrews TD, Koutsakos M, Nguyen THO, Nekrasov M, Milburn P, Eltahla A, Berry AA, Kc N, Chakravarty S, Sim BKL, Wheatley AK, Kent SJ, Hoffman SL, Lyke KE, Bejon P, Luciani F, Kedzierska K, Seder RA, Ndungu FM, Cockburn IA. Sutton HJ, et al. Among authors: chakravarty s. Cell Rep. 2021 Feb 9;34(6):108684. doi: 10.1016/j.celrep.2020.108684. Cell Rep. 2021. PMID: 33567273 Free PMC article. Clinical Trial.
A STUDY OF THE SOCIODEMOGRAPHIC AND CLINICAL PROFILES OF PSYCHIATRIC PATIENTS LEAVING AGAINST MEDICAL ADVICE.
Chakravarty S, Choudhury C, Bhandari SS, Das S. Chakravarty S, et al. Indian J Appl Res. 2020 Jul;10(7):https://www.worldwidejournals.com/indian-journal-of-applied-research-(IJAR)/article/a-study-of-the-sociodemographic-and-clinical-profiles-of-psychiatric-patients-leaving-against-medical-advice/MjA0NjE=/?is=1&b1=0&k=1. Indian J Appl Res. 2020. PMID: 32793518 Free PMC article.
Long-term Efficacy and Safety of Guselkumab, a Monoclonal Antibody Specific to the p19 Subunit of Interleukin-23, Through 2 Years: Results from a Phase 3, Randomized, Double-blind, Placebo-controlled Study Conducted in Biologic-naïve Patients with Active Psoriatic Arthritis.
McInnes IB, Rahman P, Gottlieb AB, Hsia EC, Kollmeier AP, Xu XL, Jiang Y, Sheng S, Shawi M, Chakravarty SD, van der Heijde D, Mease PJ. McInnes IB, et al. Among authors: chakravarty sd. Arthritis Rheumatol. 2021 Nov 1. doi: 10.1002/art.42010. Online ahead of print. Arthritis Rheumatol. 2021. PMID: 34719872
A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite.
Kisalu NK, Idris AH, Weidle C, Flores-Garcia Y, Flynn BJ, Sack BK, Murphy S, Schön A, Freire E, Francica JR, Miller AB, Gregory J, March S, Liao HX, Haynes BF, Wiehe K, Trama AM, Saunders KO, Gladden MA, Monroe A, Bonsignori M, Kanekiyo M, Wheatley AK, McDermott AB, Farney SK, Chuang GY, Zhang B, Kc N, Chakravarty S, Kwong PD, Sinnis P, Bhatia SN, Kappe SHI, Sim BKL, Hoffman SL, Zavala F, Pancera M, Seder RA. Kisalu NK, et al. Among authors: chakravarty s. Nat Med. 2018 May;24(4):408-416. doi: 10.1038/nm.4512. Epub 2018 Mar 19. Nat Med. 2018. PMID: 29554083 Free PMC article.
RNA-Dependent Regulation of Virulence in Pathogenic Bacteria.
Chakravarty S, Massé E. Chakravarty S, et al. Front Cell Infect Microbiol. 2019 Oct 9;9:337. doi: 10.3389/fcimb.2019.00337. eCollection 2019. Front Cell Infect Microbiol. 2019. PMID: 31649894 Free PMC article. Review.
606 results